More

    Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC



    [
    Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC
    [og_img]
    https://www.investing.com/news/press-releases/protara-therapeutics-announces-positive-interim-results-demonstrating-durable-responses-in-the-ongoing-phase-2-advanced2-trial-of-tara002-in-patients-with-nmibc-93CH-4005848


    Investing.com

    Latest articles

    spot_imgspot_img

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here

    spot_imgspot_img